MANAGEMENT AND THERAPEUTIC OUTCOMES OF INFANTILE HEMANGIOMAS IN THE PERIOCULAR REGION: A REVIEW
DOI:
https://doi.org/10.31435/ijitss.4(52).2026.6869Keywords:
Infantile Hemangioma, Periocular Region, Propranolol, Timolol, UltrasoundAbstract
Background: Infantile hemangiomas (IHs) are benign vascular tumors of early childhood characterized by rapid postnatal proliferation followed by spontaneous involution. When localized to the periocular region, these lesions present substantial functional risks, including visual axis obstruction, astigmatism, and amblyopia.
Aim: The objective of this review is to evaluate the diagnostic dynamics, ultrasound characteristics, and therapeutic efficacy of topical and systemic beta-blocker therapies in managing periocular infantile hemangiomas.
Material and Methods: A comprehensive synthesis of clinical guidelines, consensus statements, and literature regarding periocular infantile hemangiomas, diagnostic imaging, and beta-blocker management protocols was conducted.
Results: Periocular hemangiomas frequently exhibit aggressive early volumetric growth, transitioning from ambiguous superficial lesions to large mixed tumors with robust vascular signals. While topical beta-blockers (such as timolol) are effective for thin superficial components, rapidly progressing mixed and deep lesions necessitate systemic propranolol therapy. Standard dosing regimens titrated to approximately 2 mg/kg/day consistently achieve profound tumor involution, prevent permanent visual impairment, and demonstrate favorable long-term safety profiles.
Conclusion: Early multidisciplinary evaluation, serial ultrasound monitoring, and prompt initiation of beta-blocker therapy are crucial for optimizing functional and aesthetic outcomes in children with periocular infantile hemangiomas.
References
Adams, L., & Ryan, E. (2022). Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019. Australasian Journal of Dermatology, 63(4), 473–478. https://doi.org/10.1111/ajd.13906
Al-Haddad, C., El Salloukh, N. A., & El Moussawi, Z. (2019). beta-blockers in the treatment of periocular infantile hemangioma. Current Opinion in Ophthalmology, 30(5), 319–325. https://doi.org/10.1097/ICU.0000000000000591
Baruch, S., Ben Amitai, D., & Friedland, R. (2024). Rebound growth of infantile hemangiomas after propranolol versus atenolol treatment: A retrospective study. Dermatology, 240(5–6), 879–884. https://doi.org/10.1159/000542001
Ghahvehchian, H., Kashkouli, M. B., Ghanbari, S., Karimi, N., Abdolalizadeh, P., & Abri Aghdam, K. (2024). Long-term results of oral propranolol treatment protocol for periocular infantile hemangioma: Should there be any contraindication? Ophthalmic Plastic & Reconstructive Surgery, 40(1), 61–69. https://doi.org/10.1097/IOP.0000000000002507
Ginguerra, M. A., Saito, O., Fernandes, J. B. V. D., Castro, D. S., & Matayoshi, S. (2018). Clinical and radiological evaluation of periocular infantile hemangioma treated with oral propranolol: A case series. American Journal of Ophthalmology, 185, 48–55. https://doi.org/10.1016/j.ajo.2017.10.021
Goldenberg, D. C., Vikkula, M., Penington, A., Blei, F., Kool, L. S., Wassef, M., Frieden, I. J., & ISSVA Vascular Anomalies Classification Group. (2025). Updated classification of vascular anomalies: A living document from the International Society for the Study of Vascular Anomalies Classification Group. Journal of Vascular Anomalies, 6(2), e113. https://doi.org/10.1097/JOVA.0000000000000113
Gong, C., Yue, X., Zhang, L., Zhao, X., & Shu, Q. (2025). Prevalence and risk factors associated with the recurrence of infantile hemangiomas after discontinuation of propranolol: A systematic review and meta-analysis. Journal of Clinical Medicine, 14(21), 7846. https://doi.org/10.3390/jcm14217846
Han, K., Wei, J., Zheng, H., Li, X., Zhang, A., Ma, Y., Meng, J., & Hu, Y. (2024). Efficacy and safety of oral propranolol or topical timolol for the treatment of superficial infantile hemangiomas. Journal of Craniofacial Surgery. Advance online publication. https://doi.org/10.1097/SCS.0000000000001001
Herlihy, E. P., Kelly, J. P., Sidbury, R., Perkins, J. A., & Weiss, A. H. (2016). Visual acuity and astigmatism in periocular infantile hemangiomas treated with oral beta-blocker versus intralesional corticosteroid injection. Journal of AAPOS, 20(1), 30–33. https://doi.org/10.1016/j.jaapos.2015.10.014
Hu, J., Pan, L., Kong, H., & Lou, J. (2026). A systematic review and meta-analysis of the efficacy and safety of propranolol versus other drugs in the treatment of infantile hemangioma. Journal of Cosmetic Dermatology, 25(2), e70750. https://doi.org/10.1111/jocd.70750
Ji, Y., Chen, S., Yang, K., Zhang, X., Zhou, J., Li, L., Xiang, B., Qiu, T., Dai, S., Jiang, X., Lu, G., Qiu, L., Kong, F., & Zhang, Y. (2021). Efficacy and safety of propranolol vs atenolol in infants with problematic infantile hemangiomas: A randomized clinical trial. JAMA Otolaryngology–Head & Neck Surgery, 147(7), 599–607. https://doi.org/10.1001/jamaoto.2021.0454
Krowchuk, D. P., Frieden, I. J., Mancini, A. J., Darrow, D. H., Blei, F., Greene, A. K., Annam, A., Baker, C. N., Frommelt, P. C., Hodak, A., Pate, B. M., Pelletier, J. L., Sandrock, D., Weinberg, S. T., Whelan, M. A., & Subcommittee on the Management of Infantile Hemangiomas. (2019). Clinical practice guideline for the management of infantile hemangiomas. Pediatrics, 143(1), e20183475. https://doi.org/10.1542/peds.2018-3475
Kutz, A. M., Aranibar, L., Lobos, N., & Wortsman, X. (2015). Color Doppler ultrasound follow-up of infantile hemangiomas and peripheral vascularity in patients treated with propranolol. Pediatric Dermatology, 32(4), 468–475. https://doi.org/10.1111/pde.12596
Kwon, E. K., Seefeldt, M., & Drolet, B. A. (2013). Infantile hemangiomas: An update. American Journal of Clinical Dermatology, 14(2), 111–123. https://doi.org/10.1007/s40257-013-0008-x
Léauté-Labrèze, C., Hoeger, P., Mazereeuw-Hautier, J., Guibaud, L., Baselga, E., Posiunas, G., Phillips, R. J., Caceres, H., Lopez Gutierrez, J. C., Ballona, R., Friedlander, S. F., Powell, J., Perek, D., Metz, B., Barbarot, S., Maruani, A., Szalai, Z. Z., Krol, A., Boccara, O., … Voisard, J. J. (2015). A randomized, controlled trial of oral propranolol in infantile hemangioma. New England Journal of Medicine, 372(8), 735–746. https://doi.org/10.1056/NEJMoa1404710
Lopez-Gutierrez, J. C. (2015). Current management of vascular tumors in the neonate. Current Pediatric Reviews, 11(3), 226–232. https://doi.org/10.2174/1573396311666150714105944
Macca, L., Altavilla, D., Di Bartolomeo, L., Irrera, N., Borgia, F., Li Pomi, F., Vaccaro, F., Squadrito, V., Squadrito, F., & Vaccaro, M. (2022). Update on treatment of infantile hemangiomas: What's new in the last five years? Frontiers in Pharmacology, 13, 879602. https://doi.org/10.3389/fphar.2022.879602
Malvindi, S., Sammarco, E., Elefante, A., Lanni, V., Cicala, D., Esposito, F., Picardi, C., Iuliano, A., Cohen, D., Mariniello, G., D'Aponte, A., Costagliola, C., Briganti, F., & Strianese, D. (2025). Real-life efficacy and safety of oral propranolol for ocular adnexal infantile hemangiomas: Observational cohort study. Frontiers in Ophthalmology, 5, 1493171. https://doi.org/10.3389/fopht.2025.1493171
Mazhar, A., Moosa, S., Abbas, A., Mallick, Y., & Samad, L. (2020). A multi-disciplinary, multimodal approach for the management of vascular anomalies. Pakistan Journal of Medical Sciences, 36(1), S14–S19. https://doi.org/10.12669/pjms.36.ICON-Suppl.1710
Qiao, J., Lin, J., Zhang, D., Li, J., Chen, C., Yu, H., Li, X., & Fang, B. (2020). Efficacy of combined topical timolol and oral propranolol for treating infantile hemangioma: A meta-analysis of randomized controlled trials. Frontiers in Pharmacology, 11, 554847. https://doi.org/10.3389/fphar.2020.554847
Samuelov, L., Kinori, M., Rychlik, K., Konanur, M., Chamlin, S. L., Rahmani, B., & Mancini, A. J. (2018). Risk factors for ocular complications in periocular infantile hemangiomas. Pediatric Dermatology, 35(4), 458–462. https://doi.org/10.1111/pde.13525
Shah, S. D., Baselga, E., McCuaig, C., Pope, E., Coulie, J., Boon, L. M., Garzon, M. C., Haggstrom, A. N., Adams, D., Drolet, B. A., Newell, B. D., Powell, J., García-Romero, M. T., Chute, C., Roe, E., Siegel, D. H., Grimes, B., & Frieden, I. J. (2016). Rebound growth of infantile hemangiomas after propranolol therapy. Pediatrics, 137(4), e20151754. https://doi.org/10.1542/peds.2015-1754
Smithson, S. L., Rademaker, M., Adams, S., Bade, S., Bekhor, P., Davidson, S., Dore, A., Drummond, C., Fischer, G., Gin, A., Grills, C., Halbert, A., Lokmic, Z., McCahon, E., Morgan, V. A., Murrell, D. F., Orchard, D., Penington, A., Purvis, D., … Phillips, R. (2017). Consensus statement for the treatment of infantile haemangiomas with propranolol. Australasian Journal of Dermatology, 58(2), 155–159. https://doi.org/10.1111/ajd.12600
Storch, C. H., & Hoeger, P. H. (2010). Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action. British Journal of Dermatology, 163(2), 269–274. https://doi.org/10.1111/j.1365-2133.2010.09848.x
Tran, A. Q., Choi, C. J., & Wester, S. T. (2016). Beta blockers in the treatment of periocular infantile hemangiomas: A review. Internal Medicine Review, 2(9), 221. https://doi.org/10.18103/imr.v2i9.221
Ye, X. X., Jin, Y. B., Lin, X. X., Ma, G., Chen, X. D., Qiu, Y. J., Chen, H., & Hu, X. J. (2012). [Topical timolol in the treatment of periocular superficial infantile hemangiomas: A prospective study]. Zhonghua Zheng Xing Wai Ke Za Zhi, 28(3), 161–164.
Zhao, J., Huang, A. H., Rainer, B. M., Kryatova, M. S., Eghrari, A. O., Wang, J., Puttgen, K. B., & Cohen, B. A. (2019). Periocular infantile hemangiomas: Characteristics, ocular sequelae, and outcomes. Pediatric Dermatology, 36(6), 830–834. https://doi.org/10.1111/pde.13925
Zhao, Z. F., Lü, R. R., Zhang, J., Huo, R., Xu, G. Q., Fu, H. B., Guo, X., Wui, J. C., & Lin, L. L. (2011). [Oral propranolol in the management of periorbital proliferating phase infantile hemangioma]. Zhonghua Zheng Xing Wai Ke Za Zhi, 27(3), 174–177.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Daria Shchebetun, Artem Shchebetun, Andrei Trutsko, Olena Abramchuk, Vladyslav Tetarchuk, Vlada Tetarchuk, Anastasiia Tanko

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

